Find recruiting clinical trials for leukaemia in the UK — including AML, ALL, CML, CLL, and myelodysplastic syndrome subtypes. See treatment pathways and where trials fit in.
Free to use — Live data from ClinicalTrials.gov — Updated hourly
Answer a few questions about your condition and we'll match you to the most relevant clinical trials.
See where clinical trials fit into your treatment journey
Acute myeloid leukaemia, fit patients
Standard: Induction chemotherapy (7+3) + consolidation
For older or less fit patients
Standard: Azacitidine + Venetoclax or low-dose cytarabine
Acute lymphoblastic leukaemia
Standard: Multi-agent chemotherapy + CNS prophylaxis, or CAR-T for relapsed
Chronic myeloid leukaemia
Standard: TKI therapy (Imatinib, Dasatinib, Nilotinib)
Acute myeloid leukaemia — rapid-growing cancer of myeloid white blood cells. Most common acute leukaemia in adults. Treatment varies by age and fitness.
Acute lymphoblastic leukaemia — most common childhood cancer but also affects adults. CAR-T cell therapy has transformed relapsed/refractory disease.
Chronic myeloid leukaemia — a success story of targeted therapy. Most patients take daily TKI tablets (like Imatinib) with excellent long-term control.
Loading trials from ClinicalTrials.gov...
CAR-T cell therapy engineers your own immune cells to recognise and attack leukaemia. It is approved for relapsed/refractory ALL and being studied in AML and other blood cancers. Multiple UK centres have active CAR-T trials.
Absolutely. Many trials specifically target older or less fit patients, particularly in AML where lower-intensity regimens like Azacitidine + Venetoclax are studied. Age alone is rarely an exclusion.
Yes. Modern trials include targeted therapies (FLT3 inhibitors, IDH inhibitors, BCL2 inhibitors like Venetoclax), immunotherapies (bispecific antibodies, CAR-T), and kinase inhibitors. Many avoid traditional chemotherapy.
Treatment phases range from a few weeks (AML induction) to years (CML TKI therapy). Most trials include a follow-up period of 1-5 years. The trial team will provide a clear timeline.
Use our search above to find trials that match your condition and location. Review the eligibility criteria carefully.
Talk to your GP or specialist about any trials you are interested in. They can help determine if a trial is appropriate for you.
Reach out to the trial team directly using the contact information on the ClinicalTrials.gov listing. They will guide you through screening.
If you meet the criteria and decide to participate, you will go through informed consent and begin the trial process.